Abstract
Background:
To describe recent cases of optic neuritis in patients who received a vaccine for COVID-19.
Methods:
Retrospective case series of patients diagnosed with optic neuritis after a recent COVID-19 vaccination with BNT162b2 (Pfizer-BioNTech), in one university-affiliated tertiary hospital, from January 2021 to June 2021. Data were obtained from medical charts.
Results:
We describe 7 patients who developed optic neuritis after immunization with the BNT162b2 vaccine.
Conclusions:
A causal relationship cannot be deduced, and the importance of COVID-19 vaccination is not challenged. However, the authors encourage a prospective monitoring and reporting system for all patients receiving COVID-19 vaccines, to further assess the spectrum of adverse events in large databases.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical),Ophthalmology
Reference19 articles.
1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med.,2020
2. Neurological Complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine;Waheed;Cureus,2021
3. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel;Mevorach;N Engl J Med.,2021
4. Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination;Shemer;Isr Med Assoc J.,2021
5. Association between vaccination with the BNT162b2 mRNA coronavirus disease 2019 vaccine and noninfectious uveitis: a Population-Based Study;Tomkins-Netzer;Ophthalmology,2022
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献